Holland Joanna, Chandurkar Vikram
Fellow, Endocrinology, University of Alberta, Edmonton, Canada.
Assistant Professor, Division of Endocrinology, Faculty of Medicine, Memorial University of Newfoundland, Health Sciences Center, St. John's, NL, Canada.
Indian J Endocrinol Metab. 2014 Jul;18(4):542-5. doi: 10.4103/2230-8210.137514.
A retrospective study detailing the circumstances surrounding diagnosis and treatment of pheochromocytomas with the associated genetic disorders.
All patients with surgically excised pheochromocytomas in the Health Sciences Center, St. John's, Newfoundland, Canada between January 2001 and December 2010 were retrospectively analyzed to determine associated familial syndromes, age, tumor size, symptomatology, and percentage of paragangliomas and bilateral pheochromocytomas. Pathology specimen reports, adrenalectomy lists and Meditech (electronic medical record) diagnostic codes provided a comprehensive database for this study.
Twenty-four patients were studied; familial disorder patients comprised 42% (10/24). Average age at diagnosis was 57 among the sporadic and 34 in familial disorder groups (P = 0.006). Average tumor size was 4.5 cm in the sporadic group and 3 cm in the familial disorder group (P = 0.19). All atypical cases including bilateral or extra-adrenal tumors and malignancy occurred in familial disorder patients.
The proportion of familial disorder patients (42%) was higher in this study than would be expected, likely a result of the relatively high incidence of hereditary autosomal dominant disorders within Newfoundland. Among familial disorder patients, the average younger age at diagnosis and the smaller tumor size suggest syndromic pheochromocytomas may develop earlier, however they are more likely to be diagnosed sooner due to biochemical surveillance testing in known genetic disorder patients. We also demonstrate a relatively high incidence of surgically resected pheochromocytomas of 4.679/million/year in Newfoundland.
一项回顾性研究,详细阐述嗜铬细胞瘤合并相关遗传疾病的诊断和治疗情况。
对2001年1月至2010年12月间在加拿大纽芬兰圣约翰健康科学中心接受手术切除嗜铬细胞瘤的所有患者进行回顾性分析,以确定相关的家族综合征、年龄、肿瘤大小、症状以及副神经节瘤和双侧嗜铬细胞瘤的比例。病理标本报告、肾上腺切除术清单和Meditech(电子病历)诊断编码为本研究提供了全面的数据库。
共研究了24例患者;家族性疾病患者占42%(10/24)。散发性病例组的平均诊断年龄为57岁,家族性疾病组为34岁(P = 0.006)。散发性病例组的平均肿瘤大小为4.5厘米,家族性疾病组为3厘米(P = 0.19)。所有非典型病例,包括双侧或肾上腺外肿瘤以及恶性肿瘤均发生在家族性疾病患者中。
本研究中家族性疾病患者的比例(42%)高于预期,这可能是由于纽芬兰遗传性常染色体显性疾病的发病率相对较高。在家族性疾病患者中,平均诊断年龄较小且肿瘤较小,这表明综合征性嗜铬细胞瘤可能发展得更早,然而由于对已知遗传疾病患者进行生化监测检查,它们更有可能更早被诊断出来。我们还证明,纽芬兰手术切除嗜铬细胞瘤的发病率相对较高,为每年4.679/百万。